Mulla, Christopher M.
Goldfine, Allison B.
Dreyfuss, Jonathan M.
Houten, Sander
Pan, Hui
Pober, David M.
Wewer Albrechtsen, Nicolai J.
Svane, Maria S.
Schmidt, Julie B.
Holst, Jens Juul
Craig, Colleen M.
McLaughlin, Tracey L.
Patti, Mary-Elizabeth http://orcid.org/0000-0002-8163-3429
Funding for this research was provided by:
Medimmune (xxxx)
Somalogic (xxx)
American Society of Metabolic and Bariatric Surgery (xxxx)
Article History
First Online: 11 April 2019
Compliance with Ethical Standards
:
: Dr. Patti has consulted for Eiger Pharmaceuticals; has received investigator-initiated grant support from Janssen Pharmaceuticals, Medimmune, Sanofi, Astra-Zeneca, Jenesis, and Nuclea; has been a site investigator for XOMA; and acknowledges clinical trial research trial product support from Ethicon, Covidien, NovoNordisk, Nestle, and Dexcom within the past 5 years. Dr. Patti and Dr. Goldfine disclose a patent application for plasma proteins contributing to hypoglycemia. Dr. Mulla, Dr. Dreyfuss, Dr. Houten, Dr. Pan, Dr. Pober, Dr. Wewer Albrechtsen, Dr. Svane, Dr. Schmidt, Dr. Holst, Dr. Craig, and Dr. McLaughlin declare no potential competing interests.